OncoveryCare Partners with Tennessee Oncology and Raises $4.5M Seed Round from .406 Ventures

2 months ago

The company is radically redefining the care model for cancer survivorship BOSTON, MA / ACCESSWIRE / May 23, 2024 /…

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

2 months ago

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted…

IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility

2 months ago

GOTHENBURG, SE / ACCESSWIRE / May 23, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 23, 2024 - IRLAB Therapeutics…

Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy

2 months ago

Data supports expanding use of PulseVet Shock Wave therapy to treat equine EIPH and equine asthma ANN ARBOR, MI /…

NanoViricides Bolsters Partnership Efforts – Engages Aagami Inc.

2 months ago

SHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in…

Vistin Pharma ASA: Minutes from the annual general meeting 2024

2 months ago

Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting…

Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal

2 months ago

Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the…

Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body’s own immune system to kill brain tumour cells in glioblastomas

2 months ago

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce $80,000 research grant has been awarded…